Here's Why Sarepta (SRPT) Stock Price Surged 57% YTD

Sarepta developed Elevidys in collaboration with Roche (RHHBY) . Both companies entered into a licensing agreement in 2019 to develop and market Elevidys. Per the agreement, Sarepta is responsible for marketing the therapy in the United States, while Roche is responsible for marketing the gene therapy outside the country. Sarepta is also eligible to receive collaboration revenues on the ex-U.S. sales made by Roche. This latest approval significantly expands the company's target market as it can increase its ...